Lifecore Biomedical/$LFCR
1D1W1MYTD1Y5YMAX
Capital at risk
About Lifecore Biomedical
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
- Ticker
- $LFCR
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 382
- Headquarters
- Chaska, United States
- Website
- www.lifecore.com
LFCR Metrics
BasicAdvanced
$247M
-
-$0.93
1.09
-
Price and volume
Market cap
$247M
Beta
1.09
52-week high
$8.98
52-week low
$3.63
Average daily volume
268K
Financial strength
Current ratio
3.491
Quick ratio
2.176
Long term debt to equity
4.181
Total debt to equity
4.22
Interest coverage (TTM)
-0.05%
Profitability
EBITDA (TTM)
8.242
Gross margin (TTM)
31.37%
Net profit margin (TTM)
-23.78%
Operating margin (TTM)
-0.97%
Effective tax rate (TTM)
-1.91%
Revenue per employee (TTM)
$340,000
Management effectiveness
Valuation
Price to revenue (TTM)
1.882
Price to book
-17.21
Price to tangible book (TTM)
-7.57
Price to free cash flow (TTM)
39.111
Free cash flow yield (TTM)
2.56%
Free cash flow per share (TTM)
0.167
Growth
What the Analysts think about LFCR
Analyst ratings (Buy, Hold, Sell) for Lifecore Biomedical stock.
Analyst projections of the future price of Lifecore Biomedical stock.
LFCR Financial Performance
Revenues and expenses
LFCR Earnings Performance
Company profitability
Upcoming events
No upcoming events
LFCR News
AllArticlesVideos
Funds containing LFCR
AllUSDGBPEUR
Fund name | Fund size | $LFCR weighting |
|---|---|---|
iShares Nasdaq US Biotechnology$BTEC | $1.2B | 0.01% |
iShares Nasdaq US Biotechnology£BTEK | £865M | 0.01% |
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.00% |
SPDR Russell 2000 US Small Cap£R2SC | £4.1B | 0.00% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.